BioInvent International AB
BINV.ST · Health Technology · Biotechnology · SE
73 employees · bioinvent.se
About
BioInvent International AB is a Swedish biopharmaceutical company specializing in the discovery and development of therapeutic antibodies. It was founded in 1986 and is headquartered in Lund, Sweden. BioInvent conducts research and development activities in the fields of immuno-oncology, inflammatory diseases, and fibrosis.
Annual results
Reported figures, SEK · revenue up 413.6% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 226M | -332M | -146.9% | — |
| 2024 | 44.0M | -429M | -975.0% | — |
| 2023 | 71.0M | -330M | -464.8% | — |
| 2022 | 326M | -34.0M | -10.4% | — |
| 2021 | 19.0M | -278M | -1463.2% | — |
BINV.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for BioInvent International AB are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.